Mirum Pharmaceuticals Inc
NASDAQ:MIRM 4:00:00 PM EDT
| Market Cap (Intraday) | 1.11B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 61.15 |
| 10-Day MA | $24.64 |
| 50-Day MA | $26.97 |
| 200-Day MA | $28.17 |
Mirum Pharmaceuticals Inc Stock, NASDAQ:MIRM
950 Tower Lane, Suite 1050, Foster City, California 94404
United States of America
Phone: +1.650.667.4085
Number of Employees: 264
Description
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.